Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henit Yanai

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Journal of Clinical Medicine|July 2, 2021
Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: A Multi-Center Retrospective Cohort StudyAhmad Albshesh, Joshua Taylor, Edoardo V Savarino, et al.
Inflammatory Bowel Diseases|August 5, 2023
Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative StudyTamás Resál, Péter Bacsur, Csilla Keresztes, et al.
Journal of Crohn'S & Colitis|June 15, 2024
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical TreatmentMichel Adamina, Silvia Minozzi, Janindra Warusavitarne, et al.
Vaccines|March 26, 2022
COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli ExperienceLev Lichtenstein, Benjamin Koslowsky, Ami Ben Ya'acov, et al.
United European Gastroenterology Journal|January 18, 2025
Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey StudyOffir Ukashi, Aurelien Amiot, David Laharie, et al.
Vaccines|July 27, 2022
Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel DiseasesKeren Masha Rabinowitz, Michal Navon, Hadar Edelman-Klapper, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2026
Ustekinumab and JAK inhibitors outperform vedolizumab as second-line therapy in anti-TNF-experienced patients with ulcerative colitisGiuseppe Privitera, Cristina Bezzio, Gisella Figlioli, et al.
Journal of Crohn'S & Colitis|October 22, 2024
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile InfectionIdan Goren, Ortal Fallek Boldes, Tomer Boldes, et al.
Journal of Crohn'S & Colitis|July 27, 2022
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European StudyHenit Yanai, Anna Kagramanova, Oleg Knyazev, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Journal of Clinical Medicine|July 2, 2021
Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: A Multi-Center Retrospective Cohort StudyAhmad Albshesh, Joshua Taylor, Edoardo V Savarino, et al.
Inflammatory Bowel Diseases|August 5, 2023
Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative StudyTamás Resál, Péter Bacsur, Csilla Keresztes, et al.
Journal of Crohn'S & Colitis|June 15, 2024
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical TreatmentMichel Adamina, Silvia Minozzi, Janindra Warusavitarne, et al.
Vaccines|March 26, 2022
COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli ExperienceLev Lichtenstein, Benjamin Koslowsky, Ami Ben Ya'acov, et al.
United European Gastroenterology Journal|January 18, 2025
Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey StudyOffir Ukashi, Aurelien Amiot, David Laharie, et al.
Vaccines|July 27, 2022
Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel DiseasesKeren Masha Rabinowitz, Michal Navon, Hadar Edelman-Klapper, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2026
Ustekinumab and JAK inhibitors outperform vedolizumab as second-line therapy in anti-TNF-experienced patients with ulcerative colitisGiuseppe Privitera, Cristina Bezzio, Gisella Figlioli, et al.
Journal of Crohn'S & Colitis|October 22, 2024
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile InfectionIdan Goren, Ortal Fallek Boldes, Tomer Boldes, et al.
Journal of Crohn'S & Colitis|July 27, 2022
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European StudyHenit Yanai, Anna Kagramanova, Oleg Knyazev, et al.
Pageof 13